News

Thermo Fisher Scientific has signed a definitive agreement with BD (Becton, Dickinson and Company) under which Thermo Fisher will acquire BD's Advanced Bioprocessing business. This…
Read More...

AstraZeneca and its partner Amgen Inc. announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for tezepelumab in patients with severe…
Read More...

Softbox announces that it is launching its MAX range at the next IQPC Annual Cold Chain Global Forum (24-27 September) in Philadelphia. Softbox’s MAX range is a new addition to the…
Read More...

Gilead Sciences and Galapagos announced that the randomized, placebo-controlled Phase 2 TORTUGA study of filgotinib, an investigational, selective JAK1 inhibitor, achieved its primary…
Read More...

LEO Pharma and Bayer announced the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States.…
Read More...

Novartis announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo…
Read More...

NHS patients to benefit from Europe’s first full access deal on breakthrough CAR-T therapy. NHS England chief executive Simon Stevens has announced today that children and young…
Read More...

DZS Clinical Services, which provides clinical development and data analytic services for global pharmaceutical, biotech and medical device companies, announced that it has been…
Read More...

WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate) for metastatic colorectal cancer from the National Medical…
Read More...

Atara Biotherapeutics announced that it has entered into a strategic collaboration with Moffitt Cancer Center to develop multi‑targeted chimeric antigen receptor T-cell (CAR T)…
Read More...

Thrombolytic Science, LLC (TSI) announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of low-dose tissue…
Read More...

ADMA Biologics, a vertically integrated commercial biopharmaceutical company that manufactures, markets and develops specialty plasma-based biologics for the prevention and treatment of…
Read More...

Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the…
Read More...

AMRI and Metrion Biosciences announced that they have signed a new collaboration agreement. The alliance will promote Metrion's electrophysiology and ion channel screening expertise to…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental Biologics License Application (sBLA) seeking accelerated…
Read More...

SGS announced that it has successfully implemented advanced techniques for the collection and use of Peripheral Blood Mononuclear Cells (PBMCs) for early phase clinical trials at its…
Read More...

Key Biologics LLC and Blood Centers of America (BCA) announced an agreement to formalize their existing business relationship and to work collectively to broaden support for cell…
Read More...

United Therapeutics Corporation and MannKind Corporation announced that they have entered into a worldwide exclusive licensing and collaboration agreement for the development and…
Read More...

Sanofi has reached a civil settlement with the U.S. Securities and Exchange Commission (SEC) fully resolving the SEC’s investigation into possible violations of the U.S. Foreign Corrupt…
Read More...

Olon S.p.A.announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India, as part of a continuing expansion of its global footprint.…
Read More...